NCT06592703View on ClinicalTrials.gov

Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 6, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Multiple Sclerosis
Interventions
DRUG

Adipose tissue-derived Mesenchymal Stromal Cells

repeated allogenic ASCs IT injections

Trial Locations (2)

Unknown

RECRUITING

APHP Henri Mondor, Créteil

NOT_YET_RECRUITING

CHU Rennes, Rennes

All Listed Sponsors
collaborator

Etablissement Français du Sang

OTHER

lead

Rennes University Hospital

OTHER